一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Pharmaceutics >>article
Pharmaceutics

Pharmaceutics

IF: 4.9
Download PDF

ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition of the Novel ROS1/TRK/ALK Inhibitor Repotrectinib, While OATP1A/1B, ABCG2, and CYP3A Limit Its Oral Availability

Published:21 October 2021 DOI: 10.3390/pharmaceutics13111761 PMID: 34834176
Wenlong Li, Rolf W Sparidans, Maria C Lebre, Jos H Beijnen, Alfred H Schinkel

Abstract

Repotrectinib shows high activity against ROS1/TRK/ALK fusion-positive cancers in preclinical studies. We explored the roles of multidrug efflux transporters ABCB1 and ABCG2, the OATP1A/1B uptake transporter(s), and the CYP3A complex in pharmacokinetics and tissue distribution of repotrectinib in genetically modified mouse models. In vitro, human ABCB1 and ABCG2, and mouse Abcg2 efficiently transported repotrectinib with efflux transport ratios of 13.5, 5.6, and 40, respectively. Oral repotrectinib (10 mg/kg) showed higher plasma exposures in Abcg2-deficient mouse strains. Brain-to-plasma ratios were increased in Abcb1a/1b-/- (4.1-fold) and Abcb1a/1b;Abcg2-/- (14.2-fold) compared to wild-type mice, but not in single Abcg2-/- mice. Small intestinal content recovery of repotrectinib was decreased 4.9-fold in Abcb1a/1b-/- and 13.6-fold in Abcb1a/1b;Abcg2-/- mice. Intriguingly, Abcb1a/1b;Abcg2-/- mice displayed transient, mild, likely CNS-localized toxicity. Oatp1a/1b deficiency caused a 2.3-fold increased oral availability and corresponding decrease in liver distribution of repotrectinib. In Cyp3a-/- mice, repotrectinib plasma AUC0-h was 2.3-fold increased, and subsequently reduced 2.0-fold in humanized CYP3A4 transgenic mice. Collectively, Abcb1 and Abcg2 restrict repotrectinib brain accumulation and possibly toxicity, and control its intestinal disposition. Abcg2 also limits repotrectinib oral availability. Oatp1a/1b mediates repotrectinib liver uptake, thus reducing its systemic exposure. Systemic exposure of repotrectinib is also substantially limited by CYP3A activity. These insights may be useful to optimize the therapeutic application of repotrectinib.

Substances (10)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Repotrectinib 1802220-02-5 C18H18FN5O2 192 suppliers $8.00-$1600.00
Repotrectinib 1802220-02-5 C18H18FN5O2 192 suppliers $8.00-$1600.00
Repotrectinib 1802220-02-5 C18H18FN5O2 192 suppliers $8.00-$1600.00
Repotrectinib 1802220-02-5 C18H18FN5O2 192 suppliers $8.00-$1600.00
TPX-0005 1802220-02-5 - Inquiry
TPX-0005 1802220-02-5 - Inquiry
TPX-0005 1802220-02-5 - Inquiry
TPX-0005 1802220-02-5 - Inquiry
TPX-0005 1802220-02-5 C18H18FN5O2 - Inquiry
TPX-0005 1802220-02-5 C18H18FN5O2 - Inquiry

Similar articles

IF:4.9

The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases.

International Journal of Molecular Sciences Min-Hyun Kim, Hyeyoung Kim,etc Published: 12 May 2017
IF:3

Study on the health risk of cyanuric acid in swimming pool water and its prevention and control measures

Frontiers in Public Health Zhe Chen, Yi Su,etc Published: 8 January 2024
井研县| 天全县| 宁晋县| 延边| 苗栗县| 大渡口区| 广灵县| 同仁县| 临武县| 淮北市| 香港 | 建水县| 翁牛特旗| 墨脱县| 南昌县| 扶风县| 金华市| 民乐县| 光山县| 宕昌县| 兰坪| 汝南县| 深水埗区| 恩施市| 泌阳县| 渝中区| 汉阴县| 富宁县| 剑河县| 海原县| 喜德县| 定南县| 成安县| 从江县| 利津县| 江西省| 潜山县| 延边| 信阳市| 长兴县| 屯门区|